← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biopowertech
Tuscaloosa, AL
$1,623,966
Total funding
8
Grants
Funding over time
peak $335.3K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,623,966 · 8
By mechanism
R43$1,623,966 · 8
Investigators at Biopowertech
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeting Deceoy Receptor 3 in Breast Cancer$335,322
R43 · FY2008 · CA
Development of recombinant rhTL1A protein for cancer treatment$329,560
R43 · FY2010 · CA
A novel biomarker of infection in neutropenic cancer patients$311,003
R43 · FY2015 · AI
A novel therapy for sepsis$203,439
R43 · FY2007 · AI
Development of immunoassay to measure a novel TNF-like protein$115,389
R43 · FY2007 · GM
A therapeutic potential of soluble decoy receptor 3 in sepsis$112,572
R43 · FY2006 · GM
Decoy receptor 3 and liver cirrhosis$109,681
R43 · FY2006 · DK
Soluble Decoy Receptor 3 in Bacterial Infection and Sepsis$107,000
R43 · FY2006 · GM